New patent expiration for Genentech Inc drug ESBRIET

Annual Drug Patent Expirations for ESBRIET Esbriet is a drug marketed by Genentech Inc and is included in two NDAs. It is available from two suppliers. There are twenty patents…

The post New patent expiration for Genentech Inc drug ESBRIET appeared first on DrugPatentWatch.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: